FDA Drug Application (202007) for ABACAVIR SULFATE; LAMIVUDINE by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number202007
Product Number001
FormTABLET, FOR SUSPENSION; ORAL
Dosage60MG; 30MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABACAVIR SULFATE; LAMIVUDINE
Active IngredientABACAVIR SULFATE; LAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient ABACAVIR SULFATE9
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by CIPLA LIMITED